Back to search

Omass Therapeutics Limited

10028228

active
Private Limited Company
england wales
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Loss before tax (-10)
  • Current liabilities exceed current assets (-10)

Details

BUILDING 4000 JOHN SMITH DRIVE, OXFORD, OX4 2GX
Incorporated 26/02/2016

Compliance

Last accounts

31/12/2025

full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 12/03/2026

Due 26/03/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Edward Eliot Hodgkin

director · Since 24/05/2017

DIRECTOR

BRITISH · ENGLAND · Age 62

Also on 4 other boards

Ms Rosamond Margaret Chevallier Deegan

director · Since 30/05/2019

DIRECTOR

BRITISH · ENGLAND · Age 53

Mr Jonathan Deane Montagu Daoust

director · Since 30/05/2019

DIRECTOR

BRITISH · GERMANY · Age 50

Mrs Nathalie Marie Berthe Michelle Franchimont

director · Since 23/07/2020

DIRECTOR

BELGIAN · UNITED STATES · Age 60

Mr Christopher Philip Ashton

director · Since 14/10/2020

DIRECTOR

BRITISH · ENGLAND · Age 66

Also on 5 other boards

Phd Laia Crespo-Martin

director · Since 19/04/2022

PARTNER AT SANOFI VENTURES

SPANISH · FRANCE · Age 52

Dr (Phd) Scott Biller

director · Since 19/04/2022

EXECUTIVE VENTURE PARTNER

AMERICAN · UNITED STATES · Age 70

Ms Diana Bernstein

director · Since 19/04/2022

DIRECTOR

AMERICAN · UNITED STATES · Age 39

Ms Carol Anne Schafer

director · Since 07/07/2025

DIRECTOR

AMERICAN · UNITED STATES · Age 62

Mr Pierre-Louis Emmanuel Joffrin

director · Since 20/05/2026

FRENCH · ENGLAND · Age 32

Also on 1 other board

Persons with Significant Control

Syncona Limited

25–50% shares
25–50% votes

PO BOX 225 Trafalgar Court, Les Banques, St Peter Port, GY1 3QL

Reg: 55514 · Guernsey · Limited Company

Notified 11/09/2018

Former PSCs

Oxford Sciences Innovation Plc

Ceased 11/09/2018

Oxford Science Enterprises Holdings Ii Limited

Ceased 11/09/2018

Charges0 outstanding

Charge
satisfied

SILICON VALLEY BANK

Created 26/06/2019Registered 01/07/2019Satisfied 22/12/2022

CompanyRankvs 140+ SIC 72110 peers
85

Financial strength99th percentile among SIC peers · 25/25
Employees98th percentile among SIC peers · 15/15
LiquidityCurrent ratio 5.53× · 20/20
Longevity10 years trading (max 15) · 10/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity10/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2020

Turnover

£0

Annual revenue

Net Worth

£13.9M

Balance sheet strength

Cash

£10.1M

Cash in the bank

Profit Before Tax

-£7.6M

Bottom line earnings

Net Current Assets

£10.3M

Working capital

Current Assets

£12.6M

Current Liabilities

£2.3M

Fixed Assets

£3.6M

Debtors

£2.5M

Cost of Sales

£0

Gross Profit

£0

Admin Expenses

£7.7M

Operating Profit

-£7.6M

28avg. employees

Balance Sheet

Intangible assets£1.2M
Assets less current liabilities£13.9M
Prepared with Companies House

EstimatesDerived

YearCurrent Ratio
20205.53

Derived from filed accounts. Not audited figures.